Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enliven Treateutics

20.51
+0.66003.32%
Post-market: 20.510.00000.00%17:43 EDT
Volume:221.18K
Turnover:4.53M
Market Cap:1.01B
PE:-10.84
High:20.79
Open:19.95
Low:19.65
Close:19.85
Loading ...
Jul 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 29, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Jul 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities